"Ethylenediamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of ethylenediamine (the structural formula NH2CH2CH2NH2).
| Descriptor ID |
D005029
|
| MeSH Number(s) |
D02.092.782.258.368
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ethylenediamines".
Below are MeSH descriptors whose meaning is more specific than "Ethylenediamines".
This graph shows the total number of publications written about "Ethylenediamines" by people in this website by year, and whether "Ethylenediamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ethylenediamines" by people in Profiles.
-
PRMT1 loss sensitizes cells to PRMT5 inhibition. Nucleic Acids Res. 2019 06 04; 47(10):5038-5048.
-
Novel drugs against tuberculosis: a clinician's perspective. Eur Respir J. 2015 Apr; 45(4):1119-31.
-
A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion. PLoS One. 2014; 9(10):e109361.
-
Synaptic release and extracellular actions of Zn2+ limit propagation of spreading depression and related events in vitro and in vivo. J Neurophysiol. 2012 Feb; 107(3):1032-41.
-
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant. 2008 May; 41(9):771-8.
-
Molecular and phenotypic characterization of transgenic soybean expressing the Arabidopsis ferric chelate reductase gene, FRO2. Planta. 2006 Oct; 224(5):1116-28.
-
Mechanisms of apoptosis in human retinal pigment epithelium induced by TNF-alpha in conditions of heavy metal ion deficiency. Invest Ophthalmol Vis Sci. 2005 Mar; 46(3):1039-46.
-
Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo. Cancer Res. 2004 Jul 15; 64(14):4875-86.
-
Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy. 2004; 6(4):344-55.
-
Technetium-99m-labeled monoclonal antibodies: influence of technetium-99m binding sites. J Nucl Med. 1994 May; 35(5):876-81.